Factors in AIDS dementia complex trial design: Results and lessons from the abacavir trial

Authors

Bruce J. Brew, National Centre in HIV Epidemiology and Clinical Research, St. Vincent’s Hospital, Darlinghurst, Sydney, Australia
Mark Halman, Saint Michael’s Hospital, Toronto, Ontario, Canada
Jose Catalan, Imperial College, London, United Kingdom
Ned Sacktor, Johns Hopkins University
Richard W. Price, San Francisco General Hospital (SFGH)
Steve Brown, University of California - Los Angeles
Hamp Atkinson, HIV Neurobehavioral Research Center, San Diego
David B. Clifford, Washington University School of Medicine in St. Louis
David Simpson, Mt. Sinai Medical Center, New York, New York
Gabriel Torres, St. Vincent’s Hospital, New York, New York
Colin Hall, University of North Carolina at Chapel Hill
Christopher Power, University of Manitoba Faculty of Medicine
Justin C. Mc Arthur, Johns Hopkins University
William Symonds, GlaxoWellcome, Research Triangle, North Carolina
Carmen Romero, GlaxoWellcome, Madrid, Spain

Journal

PLoS Clinical Trials

Publication Date

2007

Volume

2

Issue

3

Inclusive Pages

e13

Document Type

Open Access Publication

DOI

10.1371/journal.pctr.0020013

Rights and Permissions

Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, et al. (2007) Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial. PLOS Clin Trial 2(3): e13. doi:10.1371/journal.pctr.0020013

Recommended Citation

Brew, Bruce J.; Halman, Mark; Catalan, Jose; Sacktor, Ned; Price, Richard W.; Brown, Steve; Atkinson, Hamp; Clifford, David B.; Simpson, David; Torres, Gabriel; Hall, Colin; Power, Christopher; Mc Arthur, Justin C.; Symonds, William; and Romero, Carmen, "Factors in AIDS dementia complex trial design: Results and lessons from the abacavir trial." PLoS Clinical Trials. 2, 3. e13. (2007).
https://digitalcommons.wustl.edu/open_access_pubs/850